RANTES production from mononuclear cells in response to the specific allergen in asthma patients

Allergology International

Volumn 55, Issue 3, 2006, Pages 253-259

  Oyamada, Hajime ^a   Kamada, Yumiko ^a   Saito, Norihiro ^a   Tsuda, Akira ^a   Urayama, Osamu ^a   Yamada, Hidekazu ^b   Hirasawa, Hiroyuki ^a   Yamaguchi, Kazutoshi ^a   Ueki, Shigeharu ^a   Chihara, Junichi ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Asthma; Chemokine; Eosinophil; Mononuclear cells; Platelets; RANTES

Indexed keywords

ALLERGEN; CD4 ANTIGEN; CD8 ANTIGEN; EOTAXIN; RANTES;

ADULT; ALLERGIC ASTHMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; HUMAN; MONONUCLEAR CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 33748935287     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.55.253     Document Type: Article

References (43)

1. Bousquet J, Chanez P, Lacoste JY et al. Eosinophilic inflammation in asthma. N. Engl. J. Med. 1990;323:1033-1038.
2. Chihara J. Molecular mechanisms of eosinophil activation in allergic diseases. Clin. Exp. All. Rev. 2005;5:46-49.
3. Lee JJ, Dimina D, Macias MP et al. Defining a link with asthma in mice congenitally deficient in eosinophils. Science 2004;305:1773-1776.
4. Rothenberg ME. Eosinophilia. N. Engl. J. Med. 1998;338:1592-1600.
5. Nagai H. Immunopharmacological approach to elucidation the mechanism of allergic inflammation. Allergol. Int. 2005;54:251-261.
6. Terada N, Gorai S, Kim WJ et al. Mechanisms of eosinophilic inflammation in the mucosa of the nasal cavity and paranasal sinus. Allergol. Int. 2001;50:273-279.
7. Gleich GJ, Adolphson CR. The eosinophilic leukocyte. Adv. Immune. 1986;39:177-253.
8. Page CP. Platelet as inflammatory cells. Immunopharmacology 1989;17:51-59.
9. Capron A, Ameisen JC, Joseph M et al. New functions for platelets and their pathological implications. Int. Arch. Allergy Immunol. 1985;77:107-114.
10. Chihara J, Kurachi D, Yamamoto T et al. Induction of β2 integrin expression on an eosinophilic cell line (EoL-1) by the supernatant of mononuclear cells stimulated with specific allergen from asthmatic patients. Immunol. Lett. 1994 ;42:25-29.
11. Baggiolini M, Dahinden CA. CC chemokines in allergic inflammation. Immunology Today 1994;15:127-133.
12. Stoeckle MY, Barker KA Two burgeoning families of platelet factor 4-related proteins; Mediators of the inflammatory response. The New Biologist 1990;4:313-323.
13. Schall TJ. Biology of the RANTES/SIS cytokine family. Cytokine 1991;3:165-183.
14. Bisset LR, Schmid-Grendelmeier P. Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective. Curr. Opin. Pulm. Med. 2005;11:35-42.
15. Schall TJ, Bacon K, Toy KJ et al. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990;347:669-671.
16. McLean A. Regulation of RANTES. Lancet 1994;343:189-190.
17. Kameyoshi Y, Doorschner A, Mallet AI et al. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J. Exp. Med. 1992;176:587-592.
18. American Thoracic Society. Pulmonary terms and symbols. Chest 1975;67:583-589.
19. Chihara J, Nakano N, Kurachi D et al. Induction of IgE-Fc receptor (FcR2/CD23) expression on lymphocytes from patients with mite-allergic bronchial asthma by mite allergen. Ann. Allergy 1991;67:429-432.
20. Chihara J, Yamada H, Takamura E et al. Possible presence of RANTES in the tear of patients with allergic conjunctivitis. Int. Arch. Allergy Immunol. 1995;106:428-429.
21. Chihara J, Yasuba H, Tsuda A et al. Elevation of the plasma level of RANTES during asthma attacks. J. Allergy Clin. Immunol. 1997;100:S52-55.
22. Chihara J, Oyamada H, Yamada H et al. Expression of mRNA for RANTES in human eosinophils. Int. Arch. Allergy Immunol. 1997;114(S1):33-35.
23. Djukanovic R, Roche WR, Wilson JW et al. Mucosal inflammation in asthma. Am. Rev. Respir. Dis. 1990;142:434-457.
24. Lampinen M, Carlson M, Hakansson TD et al. Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 2004;59:793-805.
25. +) memory T cells predominate in the CD4 cellular infiltrate associated with allergen-induced late-phase skin reactions in atopic subjects. Clin. Exp. Immunol. 1991;84:270-274.
26. Frew AJ, Kay AB. The relationship between infiltrating CD4 lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man. J. Immunol. 1988;141:4158-4164.
27. Kay AB, Ying S, Varney V et al. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and in allergen-induced late-phase cutaneous reactions in atopic subjects. J. Exp. Med. 1991;173:775-778.
28. Chihara J, Yamada H, Yamamoto T et al. Priming effect of RANTES on eosinophil oxidative metabolism. Allergy 1998;53:1178-1182.
29. Alam R, Stafford S, Forsythe P et al. RANTES is chemotactic and activating factor for human eosinophils. J. Immunol. 1993;150:3442-3448.
30. Kulmburg PA, Huber NE, Scheer BJ et al. Immunoglobulin E plus antigen challenge induces a novel intercrine/chemokine in mouse mast cells. J. Exp. Med. 1992;176:1773-1778.
31. Tanaka Y, Adams DH, Hubscher S et al. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1. Nature 1993;361:79-82.
32. Taub DD, Conlon K, Lloyd AR et al. Preferential migration of activated CD4 and CD8 T cells in response to MIP-1 and MIP-1. Science 1993;260:355-358.
33. Zhang L, Redington AE, Holgate ST. RANTES; a novel mediator of allergic inflammation. Clin. Exp. Allergy 1994;24:899-904.
34. Pods R, Ross D, van Hulst S et al. RANTES, eotaxin and eotaxin-2 expression and production in patients with aspirin triad. Allergy 2003;58:1165-1170.
35. Frew AJ, Kay AB. Eosinophils and T-lymphocytes in late phase allergic reactions. J. Allergy Clin. Immunol. 1990;85 :533-539.
36. Schall TJ, Jongstra J, Dyer BJ et al. A human T cell-specific molecule is a member of a new gene family. J. Immunol. 1988;141:1018-1025.
37. Kawano T, Matsuse H, Kondo Y et al. Cysteinyl leukotrienes induce nuclear factor κB activation and RANTES production in a murine model of asthma. J. Allergy Clin. Immunol. 2003;112:369-374.
38. Watanabe K, Jose PJ, Rankin SM. Eotaxin-2 generation is differentially regulated by lipopolysaccharide and IL-4 in monocytes and macropages. J. Immunol. 2002;168:1911-1918.
39. Fahy O, Hammad H, Senechal S et al. Synergistic effect of diesel organic extracts and allergen Der p I on the release of chemokines by peripheral blood mononuclear cells from allergic subjects. Am. J. Respir. Cell Mol. Biol. 2000;23:247-254.
40. Chihara J, Kurachi D, Yamamoto T et al. [Role of CD4 positive mononuclear cells in IL-5 production in response to specific allergen in asthma.]. Jpn. J. Allergology 1992;41:1017 (Abstract in Japanese).
41. Hariharan D, HoW, Cutilli J et al. C-C chemokine profile of cord blood mononuclear cell. Blood 2000;95:715-718.
42. Rathanaswami P, Hachicha M, Sadick M et al. Expression of the cytokine RANTES in human synovial rheumatoid fibroblasts; differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J. Biol. Chem. 1993;268:5834-5839.
43. Devergne O, Koka AM, Schall TJ et al. Production of the RANTES chemokine in Delayed-type hypersensitivity reactions; involvement of macrophages and endothelial cells. J. Exp. Med. 1994;179:1689-1694.